What Is Clinical Trial Transparency and Why It Matters for Pharma Companies
In the modern landscape of drug development, the concept of "open science" has moved from a voluntary ethical ideal to a strict regulatory mandate. Clinical trial transparency involves the timely public disclosure of clinical study protocols and results, as well as the sharing of anonymized patient-level data. For pharmaceutical companies, this transparency is no longer just a compliance checkbox; it is a foundational element of corporate reputation and patient trust.
